At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 29 enrolled
Drug / intervention
Brain Computer Interface Keyboarddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
P300 Brain Computer Interface Keyboard to Operate Assistive Technology
In Brief
A Phase 2 clinical trial evaluating Brain Computer Interface Keyboard for Healthy and 4 related conditions. Completed, enrolled 29 participants across 2 sites.
Detailed Summary
The purpose of this research is to develop tools enable people who are paralyzed to operate technology and access computers. These tools are called brain computer interfaces (BCIs). BCIs would let a person use brain signals to operate technology.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Amyotrophic Lateral Sclerosis, Neuromuscular Disease, Spinal Cord Injury, Cerebral Palsy
CountriesUnited States
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedMar 2009
Primary CompletionMay 2012
TodayJul 2026
First PostedMar 13, 2009
Enrollment StartSep 1, 2008
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 17.3 years ago
Interventions
Brain Computer Interface Keyboarddevice
Subjects will wear an EEG cap for 1-4 hours (1-2 hours typical) per session and use the brain-computer interface to operate assistive technology. Subjects will be asked to participate in 3 sessions.